Startups
We provide rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. We are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialisation of pharmaceutical products.
Our current portfolio of antidotes counteract certain snake venoms and the toxicity associated with some heart and cancer medications.
Our current portfolio of antidotes counteract certain snake venoms and the toxicity associated with some heart and cancer medications.
Overview
Location
United Kingdom, Wales, Llandysul
Employees
201-500
Founded date
1948
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 1, 2021 | First Evidence of High-Dose Methotrexate Related Toxicity in Spain Presented at Virtual ISPOR Europe 2021 | COPENHAGEN, Denmark, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The first evidence of high dose methotrexate related toxicity (HDMTX) in Spain was presented today at Virtual ISPOR Europe 2021, a global conference on healthcare economics and outcomes... |
| Mar 2, 2021 | SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines | |
| Mar 2, 2021 | SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines | LONDON, March 2, 2021 /PRNewswire/ -- SERB Specialty Pharmaceuticals ("SERB"), a leading European specialty pharmaceutical group focused on prescription medicines that address rare and life-threatening diseases, today announced th... |
Reviews 0
FAQ about BTG Specialty Pharmaceuticals
When was BTG Specialty Pharmaceuticals founded?
BTG Specialty Pharmaceuticals was founded in 1948.
What has the press written about BTG Specialty Pharmaceuticals?
Parsers VC has collected 4 articles mentioning BTG Specialty Pharmaceuticals, among them “First Evidence of High-Dose Methotrexate Related Toxicity in Spain Presented at Virtual ISPOR Europe 2021” (Dec 1, 2021) and “SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines” (Mar 2, 2021).
Is BTG Specialty Pharmaceuticals still active?
Yes, BTG Specialty Pharmaceuticals is active; its latest activity on Parsers VC dates from Dec 2, 2021.